Literature DB >> 20575628

Impact of enhanced external counterpulsation on Canadian Cardiovascular Society angina class in patients with chronic stable angina: a meta-analysis.

Sachin A Shah1, Robert J Shapiro, Rina Mehta, Jeffrey A Snyder.   

Abstract

STUDY
OBJECTIVE: To evaluate the true magnitude of benefit from enhanced external counterpulsation (EECP) by determining the effect of EECP on Canadian Cardiovascular Society (CCS) angina class in patients with chronic stable angina.
DESIGN: Meta-analysis of 13 prospective studies that evaluated patients with stable angina and reported adequate data on CCS angina class. PATIENTS: A total of 949 adult patients with stable angina who underwent EECP treatment.
MEASUREMENTS AND MAIN RESULTS: A systematic literature search of studies published between 1950 and February 2009 was performed. Studies were included for meta-analysis if they were reported in the English language, included human subjects, had a prospective study design, and reported adequate data on CCS angina class. The EECP treatment consisted of 35 sessions-1 hour/day, 5 days/week, for 7 weeks. Improvement in angina class was reported as the weighted proportion of patients improving by at least one CCS class from before to after EECP treatment. Heterogeneity was assessed by performing subgroup analyses and using the Cochran Q statistic. Publication bias was assessed by inspection of funnel plots and the Egger bias statistic. Among the 13 studies incorporating 949 patients, angina class was reduced by at least one CCS score in 86% of the patients (95% confidence interval 82-90%, Q statistic p=0.008]. Inspection of funnel plots showed some asymmetry, but the Egger bias statistic showed no publication bias (p=0.97).
CONCLUSION: The results of our meta-analysis call for further long-term studies to determine the place of EECP therapy in the management of chronic stable angina. Currently, EECP therapy should be considered for patients with stable angina who are refractory to or not suitable for invasive therapy and/or medical management.

Entities:  

Mesh:

Year:  2010        PMID: 20575628     DOI: 10.1592/phco.30.7.639

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  7 in total

1.  Effect of Enhanced External Counter Pulsation Treatment on Aortic Blood Pressure, Arterial Stiffness and Ejection Fraction in Patients with Coronary Artery Disease.

Authors:  Ramasamy Subramanian; Sushma Nayar; Chokkalingam Meyyappan; N Ganesh; Arumugam Chandrakasu; Pradeep G Nayar
Journal:  J Clin Diagn Res       Date:  2016-10-01

Review 2.  New Advances in the Management of Refractory Angina Pectoris.

Authors:  Kevin Cheng; Ranil de Silva
Journal:  Eur Cardiol       Date:  2018-08

Review 3.  Management of Refractory Angina Pectoris.

Authors:  Kevin Cheng; Paul Sainsbury; Michael Fisher; Ranil de Silva
Journal:  Eur Cardiol       Date:  2016-12

4.  A multi-disciplinary care pathway improves symptoms, QoL and medication use in refractory angina.

Authors:  Kevin Cheng; Ranil de Silva
Journal:  Br J Cardiol       Date:  2020-05-20

Review 5.  Management standards for stable coronary artery disease in India.

Authors:  Sundeep Mishra; Saumitra Ray; Jamshed J Dalal; J P S Sawhney; S Ramakrishnan; Tiny Nair; S S Iyengar; V K Bahl
Journal:  Indian Heart J       Date:  2016-12-09

Review 6.  Enhanced external counterpulsation: A unique treatment for the "No-Option" refractory angina patient.

Authors:  Jose Caceres; Patricia Atal; Rohit Arora; Derek Yee
Journal:  J Clin Pharm Ther       Date:  2021-01-07       Impact factor: 2.512

7.  Efficacy of Enhanced External Counterpulsation in Patients With Chronic Refractory Angina on Canadian Cardiovascular Society (CCS) Angina Class: An Updated Meta-Analysis.

Authors:  Chunmei Zhang; Xiangjuan Liu; Xiaomeng Wang; Qi Wang; Yun Zhang; Zhiming Ge
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.